Italian journal of dermatology and venereologyHumansRetrospective StudiesAntibodiesMonoclonalHumanized
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.
Michela Starace, Stephano Cedirian, Luca Rapparini, Corrado Zengarini, Laura Gandolfi, Giulio Gualdi, Fabio Lobefaro, Pietro Sollena, Pietro Quaglino, Simone Ribero, Martina Merli, Elisabetta Fulgione, Paola Vitiello, Giovanni Paolino, Franco Rongioletti
Published: 202510.23736/S2784-8671.25.08294-5
Abstract
BACKGROUND: Bruton's Tyrosine Kinase Inhibitors (BTKIs) and mogamulizumab have revolutionized the treatment of hematologic malignancies, yet they are frequently associated with dermatologic adverse events (dAEs) that can impact patient quality of lif…
Preview only. Read the full abstract at the source